BioInformant (@StemCellMarket) header
BioInformant (@StemCellMarket) profile picture

Cade Hildreth, Founder: As 1ST and ONLY market research firm to specialize in the #stemcell industry, BioInformant is cited by the WSJ, Vogue, and Tony Robbins.

Washington, DC
Joined July 2014
Photo by BioInformant (@StemCellMarket)Photo by BioInformant (@StemCellMarket)Photo by BioInformant (@StemCellMarket)Photo by BioInformant (@StemCellMarket)Photo by BioInformant (@StemCellMarket)Photo by BioInformant (@StemCellMarket)Photo by BioInformant (@StemCellMarket)Photo by BioInformant (@StemCellMarket)Photo by BioInformant (@StemCellMarket)Photo by BioInformant (@StemCellMarket)
[FLASH SALE] Global Database of Regenerative Medicine (RM) Industry Investors, 2027 – Featuring 300+ Investors - bioinformant.com/product/reg…
1
137
Hong Kong Startup MiCells® Selected for China Resources-HKSTP Programme as It Advances Private Blood Banking Technology bioinformant.com/micells-chi… @Mi_cells is developing an asset-light, tech-driven approach to private blood banking, supported by patent-pending IP.
1
1
1
131
Ncardia Expands Neuroscience Portfolio with Six New Human iPSC-Derived Neuronal Models - bioinformant.com/ncardia-hum… @NcardiaStemCell
154
CellFiber Opens US Subsidiary in Philadelphia to Accelerate Scalable Manufacturing of iPSC, MSC, and CAR-T Cell Therapies - bioinformant.com/cellfiber-o…
1
310
Vector BioMed Selected as Top Lentiviral Vector Design and Manufacturing Company -bioinformant.com/vector-biom… Life Sciences Review recognizes the pure-play lentiviral vector company’s work to help Asia-Pacific healthcare providers manufacture CAR-T therapies closer to patients.
1
158
The Exosome Revolution is Here: 1 in 7 Publications Emerged in the Past Year - bioinformant.com/what-are-ex…
210
Celaid Therapeutics Raises JPY 400 million in Series B Financing to Advance Ex Vivo Hematopoietic Stem Cell (HSC) Expansion - bioinformant.com/celaid-ther…
1
320
BioInformant retweeted
Evia Bio® Announces Availability of GMP-Grade CellShield™ MSC DMSO-Free Cryopreservation Media - bioinformant.com/evia-bio-gm… Evia Bio, a leading provider of non-DMSO cryopreservation solutions, says the GMP grade of CellShield™ cryopreservation media is now available to customers.
1
213
Evia Bio® Announces Availability of GMP-Grade CellShield™ MSC DMSO-Free Cryopreservation Media - bioinformant.com/evia-bio-gm… Evia Bio, a leading provider of non-DMSO cryopreservation solutions, says the GMP grade of CellShield™ cryopreservation media is now available to customers.
1
213
Basecamp Research Raises $140M to Advance AI-Designed In Vivo Cell Therapies - bioinformant.com/basecamp-re… @Basecamp_Res
2
371
Cellares and Seoul National University Hospital Launch Proof-of-Concept for Automated Manufacturing of Gene-Modified HSPC Therapy on the Cell Shuttle® Platform - bioinformant.com/cellares-an… @snuh_official
163
Made Scientific Expands U.S. GMP Cell Therapy Network with 85,000 Sq. Ft. Pennsylvania Acquisition — Operational on Day One - bioinformant.com/made-scient…
162
How Human iPSCs are Revolutionizing Drug Discovery in 2027 - bioinformant.com/ipsc-drug-d… @NcardiaStemCell @CellDynamics @bitbio @nexelbio @Evotec
288
Flip Mycoplasma delivers performance comparable with the best PCR tests in a ready to use format with results in just 12 min & a 3 step workflow, making easier to check your cultures before investing time in the next experiment. Get a free sample kit flip-dx.com/mycoplasma #Ad
168
16 CAR-T Therapies and Counting: How the CAR-T Market Is Evolving and The Companies Leading the Charge -bioinformant.com/globally-ap… @Novartis @GileadSciences @bmsnews @LegendBiotech @JanssenUS @CARsgen_Ther @IASOBiosciences @ActImmuno @Immuneel_
1
2
364
Rose BioSolutions Debuts as Latest CGT CDMO Following GI Partners’ Acquisition of Charles River Businesses - bioinformant.com/rose-biosol…
282
Aspen Neuroscience Advances Sasineprocel, an Autologous iPSC-Based Therapy for Parkinson’s Disease, Toward Phase 3 - bioinformant.com/aspen-neuro… @AspenNeuro
1
343